LianBio annual return on equity
2021
2022
LianBio Return on Equity (ROE) Growth & History (LIANY)
LianBio's return on equity was −35.96% for fiscal 2022.
View full LianBio company overviewLianBio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −35.96% | +141.92 pp |
| 2021 | 2021-12-31 | −177.87% | — |
LianBio quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2023 | 2023-09-30 | −11.34% | −3.59 pp |
| Q2 2023 | 2023-06-30 | −9.35% | +4.25 pp |
| Q1 2023 | 2023-03-31 | −9.61% | −1.51 pp |
| Q4 2022 | 2022-12-31 | −6.86% | +68.42 pp |
| Q3 2022 | 2022-09-30 | −7.75% | — |
| Q2 2022 | 2022-06-30 | −13.60% | — |
| Q1 2022 | 2022-03-31 | −8.10% | — |
| Q4 2021 | 2021-12-31 | −75.28% | — |
LianBio return on equity trends
Between the periods ended 2021-12-31 and 2022-12-31, LianBio's return on equity increased from −177.87% to −35.96%, a change of +141.92 percentage points. The latest reported quarter, Q3 2023, shows −11.34%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LianBio source filings ↗